pharmaobservatory 0.1.8 → 0.1.9
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +84 -9
- data/docs/AnimalWelfareAssurancesResponse.md +58 -0
- data/docs/{BiomarkerAssayEvidenceResponseBuild.md → AnimalWelfareAssurancesResponseBuild.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseFreshness.md → AnimalWelfareAssurancesResponseFreshness.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseScope.md → AnimalWelfareAssurancesResponseScope.md} +2 -2
- data/docs/AnimalWelfareAssurancesRow.md +48 -0
- data/docs/BiomarkerAlleleFrequenciesResponse.md +3 -3
- data/docs/BiomarkerAssayEvidenceResponse.md +3 -3
- data/docs/BiomarkerAssayProvidersResponse.md +3 -3
- data/docs/BiomarkerAssayWhitespaceResponse.md +3 -3
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceByYearResponse.md +3 -3
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerTraversalStatusResponse.md +3 -3
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BrandCompaniesResponse.md +3 -3
- data/docs/BrandRevenueResponse.md +3 -3
- data/docs/CatalystsResponse.md +3 -3
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CliaCertificatesResponse.md +3 -3
- data/docs/CompaniesApi.md +928 -108
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesRecordAttributes.md +2 -0
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyAssetsRow.md +1 -5
- data/docs/CompanyBiomarkerCapabilityResponse.md +3 -3
- data/docs/CompanyCollaboratorsResponse.md +58 -0
- data/docs/CompanyCollaboratorsRow.md +42 -0
- data/docs/CompanyCompetitorActivityResponse.md +58 -0
- data/docs/CompanyCompetitorActivityRow.md +42 -0
- data/docs/CompanyCompetitorsResponse.md +58 -0
- data/docs/CompanyCompetitorsRow.md +66 -0
- data/docs/CompanyFinancialsResponse.md +58 -0
- data/docs/CompanyFinancialsRow.md +108 -0
- data/docs/CompanyFirmographicsResponse.md +58 -0
- data/docs/CompanyFirmographicsRow.md +80 -0
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyProgramsRow.md +1 -5
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +3 -3
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTimelineResponse.md +58 -0
- data/docs/CompanyTimelineRow.md +68 -0
- data/docs/CompanyTrialGeographyResponse.md +3 -3
- data/docs/CompanyTrialSitesResponse.md +3 -3
- data/docs/CompanyUsPatentsResponse.md +58 -0
- data/docs/CompanyUsPatentsRow.md +34 -0
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionInvestigatorOrganizationsResponse.md +58 -0
- data/docs/ConditionInvestigatorOrganizationsRow.md +44 -0
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +3 -3
- data/docs/ConditionRecruitmentDurationResponse.md +3 -3
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +3 -3
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionsApi.md +160 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsResponse.md +3 -3
- data/docs/CroFootprintResponse.md +3 -3
- data/docs/CroTrialsResponse.md +3 -3
- data/docs/DebarmentsResponse.md +3 -3
- data/docs/DrugApprovalsResponse.md +3 -3
- data/docs/DrugAspCodesResponse.md +3 -3
- data/docs/DrugBrandsResponse.md +3 -3
- data/docs/DrugCombinationsResponse.md +3 -3
- data/docs/DrugDeclaredPatentsResponse.md +3 -3
- data/docs/DrugInvestigatorsResponse.md +58 -0
- data/docs/DrugInvestigatorsRow.md +32 -0
- data/docs/DrugLabelSafetyResponse.md +3 -3
- data/docs/DrugMedicareSpendResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/DrugPatentMentionsResponse.md +3 -3
- data/docs/DrugPatentOwnersResponse.md +3 -3
- data/docs/DrugPricingResponse.md +3 -3
- data/docs/DrugRecallsResponse.md +3 -3
- data/docs/DrugRegulatoryResponse.md +3 -3
- data/docs/DrugSitesResponse.md +3 -3
- data/docs/DrugTargetsResponse.md +3 -3
- data/docs/DrugTrialConditionsResponse.md +3 -3
- data/docs/DrugTrialsResponse.md +3 -3
- data/docs/DrugVariantsResponse.md +3 -3
- data/docs/DrugsApi.md +80 -0
- data/docs/DrugsRecord.md +2 -2
- data/docs/DrugsResponse.md +3 -3
- data/docs/EnforcementEventsResponse.md +3 -3
- data/docs/EnforcementEventsRow.md +22 -4
- data/docs/GxpFacilitiesResponse.md +3 -3
- data/docs/GxpFacilitiesRow.md +27 -1
- data/docs/HospitalBedsYearlyResponse.md +3 -3
- data/docs/HospitalFacilityChangesResponse.md +3 -3
- data/docs/HospitalsApi.md +80 -0
- data/docs/HospitalsRecord.md +2 -2
- data/docs/HospitalsResponse.md +3 -3
- data/docs/ImportRefusalsResponse.md +3 -3
- data/docs/InspectionFindingsResponse.md +3 -3
- data/docs/InspectionsResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalQuarterTotalsResponse.md +3 -3
- data/docs/InvestigatorConditionsResponse.md +58 -0
- data/docs/InvestigatorConditionsRow.md +28 -0
- data/docs/InvestigatorDebarmentsResponse.md +58 -0
- data/docs/InvestigatorDebarmentsRow.md +32 -0
- data/docs/InvestigatorHospitalsResponse.md +58 -0
- data/docs/InvestigatorHospitalsRow.md +28 -0
- data/docs/InvestigatorInspectionsResponse.md +58 -0
- data/docs/InvestigatorInspectionsRow.md +46 -0
- data/docs/InvestigatorPublicationsResponse.md +58 -0
- data/docs/InvestigatorPublicationsRow.md +34 -0
- data/docs/InvestigatorTopicsResponse.md +58 -0
- data/docs/InvestigatorTopicsRow.md +34 -0
- data/docs/InvestigatorTrialsResponse.md +58 -0
- data/docs/InvestigatorTrialsRow.md +64 -0
- data/docs/InvestigatorsApi.md +1113 -0
- data/docs/InvestigatorsRecord.md +38 -0
- data/docs/InvestigatorsResponse.md +58 -0
- data/docs/InvestigatorsRow.md +70 -0
- data/docs/InvestorFundsResponse.md +3 -3
- data/docs/InvestorPortfolioResponse.md +3 -3
- data/docs/InvestorPrivateFundsResponse.md +3 -3
- data/docs/InvestorsRecord.md +2 -2
- data/docs/InvestorsResponse.md +3 -3
- data/docs/InvestorsRow.md +6 -0
- data/docs/LegalEntitiesApi.md +244 -4
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitySecFilingsResponse.md +3 -3
- data/docs/ManagersRecord.md +2 -2
- data/docs/ManagersResponse.md +3 -3
- data/docs/OrgDisclosureTrendResponse.md +3 -3
- data/docs/OrgDisclosuresResponse.md +3 -3
- data/docs/OrgRelationshipsResponse.md +3 -3
- data/docs/OwnershipObservationsResponse.md +58 -0
- data/docs/OwnershipObservationsRow.md +168 -0
- data/docs/OwnershipPercentagesResponse.md +3 -3
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipSourceCoverageResponse.md +3 -3
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesRow.md +1 -5
- data/docs/ProgramsResponse.md +3 -3
- data/docs/ProgramsRow.md +1 -1
- data/docs/RareDiseaseGenesResponse.md +3 -3
- data/docs/RareDiseaseHierarchyResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorsResponse.md +3 -3
- data/docs/RareDiseaseMappingsResponse.md +3 -3
- data/docs/RareDiseaseOrganizationsResponse.md +3 -3
- data/docs/RareDiseasePrevalenceResponse.md +3 -3
- data/docs/RareDiseaseRarityEvidenceResponse.md +3 -3
- data/docs/RareDiseaseRarityResponse.md +3 -3
- data/docs/RareDiseaseReplacementsResponse.md +3 -3
- data/docs/RareDiseaseSiteCoverageResponse.md +3 -3
- data/docs/RareDiseaseSponsorsResponse.md +3 -3
- data/docs/RareDiseaseTrialCoverageResponse.md +3 -3
- data/docs/RareDiseaseTrialSitesResponse.md +3 -3
- data/docs/RareDiseaseTrialsResponse.md +3 -3
- data/docs/RareDiseasesRecord.md +2 -2
- data/docs/RareDiseasesResponse.md +3 -3
- data/docs/RecallsResponse.md +3 -3
- data/docs/RwdConductorDeliveryResponse.md +3 -3
- data/docs/RwdConductorFootprintResponse.md +3 -3
- data/docs/RwdConductorStudiesResponse.md +3 -3
- data/docs/RwdConductorsRecord.md +2 -2
- data/docs/RwdConductorsResponse.md +3 -3
- data/docs/RwdCoverageResponse.md +3 -3
- data/docs/RwdInstitutionsRecord.md +2 -2
- data/docs/RwdInstitutionsResponse.md +3 -3
- data/docs/RwdNetworksRecord.md +2 -2
- data/docs/RwdNetworksResponse.md +3 -3
- data/docs/RwdRegisterProvenanceResponse.md +3 -3
- data/docs/RwdRegistersRecord.md +2 -2
- data/docs/RwdSourceAgeBandsResponse.md +3 -3
- data/docs/RwdSourceConditionsResponse.md +3 -3
- data/docs/RwdSourceEtlMappingsResponse.md +3 -3
- data/docs/RwdSourceLinkagesResponse.md +3 -3
- data/docs/RwdSourceTypesResponse.md +3 -3
- data/docs/RwdSourceVocabulariesResponse.md +3 -3
- data/docs/RwdSourcesRecord.md +2 -2
- data/docs/RwdSourcesResponse.md +3 -3
- data/docs/RwdStudiesRecord.md +2 -2
- data/docs/RwdStudiesResponse.md +3 -3
- data/docs/RwdStudyConditionsResponse.md +3 -3
- data/docs/RwdStudyDataSourcesResponse.md +3 -3
- data/docs/RwdStudyDrugsResponse.md +3 -3
- data/docs/RwdStudyMilestonesResponse.md +3 -3
- data/docs/RwdWithheldFieldsResponse.md +3 -3
- data/docs/SbtiCrosscheckResponse.md +3 -3
- data/docs/SecPdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorDeliveryResponse.md +3 -3
- data/docs/SponsorPatentMentionsResponse.md +3 -3
- data/docs/SponsorPublicationsResponse.md +58 -0
- data/docs/SponsorPublicationsRow.md +42 -0
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialConditionsResponse.md +3 -3
- data/docs/SponsorTrialDrugsResponse.md +3 -3
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SupplierCapabilityEsgResponse.md +3 -3
- data/docs/SupplierServicesResponse.md +3 -3
- data/docs/SupplierSitesResponse.md +3 -3
- data/docs/SuppliersRecord.md +2 -2
- data/docs/SuppliersResponse.md +3 -3
- data/docs/SuppliersRow.md +2 -0
- data/docs/TargetAssociationsResponse.md +3 -3
- data/docs/TargetCrowdingResponse.md +3 -3
- data/docs/TargetDrugsResponse.md +3 -3
- data/docs/TargetEvidenceResponse.md +3 -3
- data/docs/TargetInvestigatorsResponse.md +58 -0
- data/docs/TargetInvestigatorsRow.md +30 -0
- data/docs/TargetPatentMentionsResponse.md +3 -3
- data/docs/TargetProgramsResponse.md +3 -3
- data/docs/TargetPublicationsResponse.md +3 -3
- data/docs/TargetRegulatoryPrecedentResponse.md +3 -3
- data/docs/TargetTrialsResponse.md +3 -3
- data/docs/TargetsApi.md +80 -0
- data/docs/TargetsRecord.md +2 -2
- data/docs/TargetsResponse.md +3 -3
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +3 -3
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +3 -3
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +3 -3
- data/docs/TrialSiteHistoryResponse.md +3 -3
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/docs/UnmatchedProductRevenueResponse.md +3 -3
- data/docs/UntitledLettersResponse.md +3 -3
- data/docs/WarningLettersResponse.md +3 -3
- data/lib/pharmaobservatory/api/companies_api.rb +1032 -122
- data/lib/pharmaobservatory/api/conditions_api.rb +168 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +84 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +84 -0
- data/lib/pharmaobservatory/api/investigators_api.rb +1169 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +254 -2
- data/lib/pharmaobservatory/api/targets_api.rb +84 -0
- data/lib/pharmaobservatory/models/animal_welfare_assurances_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_build.rb → animal_welfare_assurances_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_freshness.rb → animal_welfare_assurances_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_scope.rb → animal_welfare_assurances_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/animal_welfare_assurances_row.rb +392 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/catalysts_response.rb +3 -3
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +10 -1
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_row.rb +2 -24
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_collaborators_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_collaborators_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitors_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitors_row.rb +493 -0
- data/lib/pharmaobservatory/models/company_financials_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_financials_row.rb +718 -0
- data/lib/pharmaobservatory/models/company_firmographics_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_firmographics_row.rb +566 -0
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_row.rb +2 -24
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_timeline_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_timeline_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_us_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_us_patents_row.rb +311 -0
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_investigator_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_investigator_organizations_row.rb +366 -0
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/debarments_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_brands_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_investigators_row.rb +302 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_variants_response.rb +3 -3
- data/lib/pharmaobservatory/models/drugs_record.rb +2 -2
- data/lib/pharmaobservatory/models/drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +104 -5
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +3 -3
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +145 -2
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospitals_record.rb +2 -2
- data/lib/pharmaobservatory/models/hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/import_refusals_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspections_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +3 -3
- data/lib/pharmaobservatory/models/investigator_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_conditions_row.rb +278 -0
- data/lib/pharmaobservatory/models/investigator_debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_debarments_row.rb +300 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_row.rb +280 -0
- data/lib/pharmaobservatory/models/investigator_inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_inspections_row.rb +377 -0
- data/lib/pharmaobservatory/models/investigator_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_publications_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_topics_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_topics_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_trials_row.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_record.rb +385 -0
- data/lib/pharmaobservatory/models/investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_row.rb +511 -0
- data/lib/pharmaobservatory/models/investor_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_record.rb +2 -2
- data/lib/pharmaobservatory/models/investors_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_row.rb +34 -1
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +3 -3
- data/lib/pharmaobservatory/models/managers_record.rb +2 -2
- data/lib/pharmaobservatory/models/managers_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_relationships_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_observations_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_observations_row.rb +1048 -0
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +2 -24
- data/lib/pharmaobservatory/models/programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/programs_row.rb +1 -1
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +2 -2
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +3 -3
- data/lib/pharmaobservatory/models/recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +3 -3
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +3 -3
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_publications_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_services_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_record.rb +2 -2
- data/lib/pharmaobservatory/models/suppliers_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_row.rb +12 -1
- data/lib/pharmaobservatory/models/target_associations_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_crowding_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_investigators_row.rb +291 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/targets_record.rb +2 -2
- data/lib/pharmaobservatory/models/targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +3 -3
- data/lib/pharmaobservatory/models/warning_letters_response.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +47 -3
- metadata +96 -8
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<TrialOutcomeMeasuresRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<TrialResearchPaymentsRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<TrialSiteHistoryRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<TrialSitesRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -74,8 +74,8 @@ module PharmaObservatory
|
|
|
74
74
|
:'datasets' => :'Array<DatasetListing>',
|
|
75
75
|
:'attribution' => :'Array<DatasetAttribution>',
|
|
76
76
|
:'source_credit' => :'String',
|
|
77
|
-
:'freshness' => :'
|
|
78
|
-
:'build' => :'
|
|
77
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
78
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
79
79
|
:'build_state' => :'DatasetBuildState',
|
|
80
80
|
:'restriction' => :'Hash<String, Object>'
|
|
81
81
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<TrialsRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<UnmatchedProductRevenueRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<UntitledLettersRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
|
@@ -102,7 +102,7 @@ module PharmaObservatory
|
|
|
102
102
|
:'grain' => :'String',
|
|
103
103
|
:'object_type' => :'String',
|
|
104
104
|
:'id' => :'String',
|
|
105
|
-
:'scope' => :'
|
|
105
|
+
:'scope' => :'AnimalWelfareAssurancesResponseScope',
|
|
106
106
|
:'columns' => :'Array<DatasetColumn>',
|
|
107
107
|
:'rows' => :'Array<WarningLettersRow>',
|
|
108
108
|
:'total' => :'Integer',
|
|
@@ -115,8 +115,8 @@ module PharmaObservatory
|
|
|
115
115
|
:'source_credit' => :'String',
|
|
116
116
|
:'withheld_tiers' => :'Array<String>',
|
|
117
117
|
:'withheld_columns' => :'Array<String>',
|
|
118
|
-
:'freshness' => :'
|
|
119
|
-
:'build' => :'
|
|
118
|
+
:'freshness' => :'AnimalWelfareAssurancesResponseFreshness',
|
|
119
|
+
:'build' => :'AnimalWelfareAssurancesResponseBuild',
|
|
120
120
|
:'build_state' => :'DatasetBuildState',
|
|
121
121
|
:'restriction' => :'Hash<String, Object>'
|
|
122
122
|
}
|
data/lib/pharmaobservatory.rb
CHANGED
|
@@ -17,6 +17,11 @@ require 'pharmaobservatory/version'
|
|
|
17
17
|
require 'pharmaobservatory/configuration'
|
|
18
18
|
|
|
19
19
|
# Models
|
|
20
|
+
require 'pharmaobservatory/models/animal_welfare_assurances_response'
|
|
21
|
+
require 'pharmaobservatory/models/animal_welfare_assurances_response_build'
|
|
22
|
+
require 'pharmaobservatory/models/animal_welfare_assurances_response_freshness'
|
|
23
|
+
require 'pharmaobservatory/models/animal_welfare_assurances_response_scope'
|
|
24
|
+
require 'pharmaobservatory/models/animal_welfare_assurances_row'
|
|
20
25
|
require 'pharmaobservatory/models/api_v1_whoami_get200_response'
|
|
21
26
|
require 'pharmaobservatory/models/api_v1_whoami_get200_response_limits'
|
|
22
27
|
require 'pharmaobservatory/models/api_v1_whoami_get200_response_quota'
|
|
@@ -26,9 +31,6 @@ require 'pharmaobservatory/models/auth_error'
|
|
|
26
31
|
require 'pharmaobservatory/models/biomarker_allele_frequencies_response'
|
|
27
32
|
require 'pharmaobservatory/models/biomarker_allele_frequencies_row'
|
|
28
33
|
require 'pharmaobservatory/models/biomarker_assay_evidence_response'
|
|
29
|
-
require 'pharmaobservatory/models/biomarker_assay_evidence_response_build'
|
|
30
|
-
require 'pharmaobservatory/models/biomarker_assay_evidence_response_freshness'
|
|
31
|
-
require 'pharmaobservatory/models/biomarker_assay_evidence_response_scope'
|
|
32
34
|
require 'pharmaobservatory/models/biomarker_assay_evidence_row'
|
|
33
35
|
require 'pharmaobservatory/models/biomarker_assay_providers_response'
|
|
34
36
|
require 'pharmaobservatory/models/biomarker_assay_providers_row'
|
|
@@ -80,6 +82,16 @@ require 'pharmaobservatory/models/company_assets_response'
|
|
|
80
82
|
require 'pharmaobservatory/models/company_assets_row'
|
|
81
83
|
require 'pharmaobservatory/models/company_biomarker_capability_response'
|
|
82
84
|
require 'pharmaobservatory/models/company_biomarker_capability_row'
|
|
85
|
+
require 'pharmaobservatory/models/company_collaborators_response'
|
|
86
|
+
require 'pharmaobservatory/models/company_collaborators_row'
|
|
87
|
+
require 'pharmaobservatory/models/company_competitor_activity_response'
|
|
88
|
+
require 'pharmaobservatory/models/company_competitor_activity_row'
|
|
89
|
+
require 'pharmaobservatory/models/company_competitors_response'
|
|
90
|
+
require 'pharmaobservatory/models/company_competitors_row'
|
|
91
|
+
require 'pharmaobservatory/models/company_financials_response'
|
|
92
|
+
require 'pharmaobservatory/models/company_financials_row'
|
|
93
|
+
require 'pharmaobservatory/models/company_firmographics_response'
|
|
94
|
+
require 'pharmaobservatory/models/company_firmographics_row'
|
|
83
95
|
require 'pharmaobservatory/models/company_funding_events_response'
|
|
84
96
|
require 'pharmaobservatory/models/company_funding_events_row'
|
|
85
97
|
require 'pharmaobservatory/models/company_funding_summary_response'
|
|
@@ -92,10 +104,14 @@ require 'pharmaobservatory/models/company_rare_disease_declarations_response'
|
|
|
92
104
|
require 'pharmaobservatory/models/company_rare_disease_declarations_row'
|
|
93
105
|
require 'pharmaobservatory/models/company_targets_response'
|
|
94
106
|
require 'pharmaobservatory/models/company_targets_row'
|
|
107
|
+
require 'pharmaobservatory/models/company_timeline_response'
|
|
108
|
+
require 'pharmaobservatory/models/company_timeline_row'
|
|
95
109
|
require 'pharmaobservatory/models/company_trial_geography_response'
|
|
96
110
|
require 'pharmaobservatory/models/company_trial_geography_row'
|
|
97
111
|
require 'pharmaobservatory/models/company_trial_sites_response'
|
|
98
112
|
require 'pharmaobservatory/models/company_trial_sites_row'
|
|
113
|
+
require 'pharmaobservatory/models/company_us_patents_response'
|
|
114
|
+
require 'pharmaobservatory/models/company_us_patents_row'
|
|
99
115
|
require 'pharmaobservatory/models/condition_adverse_events_response'
|
|
100
116
|
require 'pharmaobservatory/models/condition_adverse_events_row'
|
|
101
117
|
require 'pharmaobservatory/models/condition_burden_response'
|
|
@@ -104,6 +120,8 @@ require 'pharmaobservatory/models/condition_delivery_response'
|
|
|
104
120
|
require 'pharmaobservatory/models/condition_delivery_row'
|
|
105
121
|
require 'pharmaobservatory/models/condition_drugs_response'
|
|
106
122
|
require 'pharmaobservatory/models/condition_drugs_row'
|
|
123
|
+
require 'pharmaobservatory/models/condition_investigator_organizations_response'
|
|
124
|
+
require 'pharmaobservatory/models/condition_investigator_organizations_row'
|
|
107
125
|
require 'pharmaobservatory/models/condition_prevalence_response'
|
|
108
126
|
require 'pharmaobservatory/models/condition_prevalence_row'
|
|
109
127
|
require 'pharmaobservatory/models/condition_publications_response'
|
|
@@ -144,6 +162,8 @@ require 'pharmaobservatory/models/drug_combinations_response'
|
|
|
144
162
|
require 'pharmaobservatory/models/drug_combinations_row'
|
|
145
163
|
require 'pharmaobservatory/models/drug_declared_patents_response'
|
|
146
164
|
require 'pharmaobservatory/models/drug_declared_patents_row'
|
|
165
|
+
require 'pharmaobservatory/models/drug_investigators_response'
|
|
166
|
+
require 'pharmaobservatory/models/drug_investigators_row'
|
|
147
167
|
require 'pharmaobservatory/models/drug_label_safety_response'
|
|
148
168
|
require 'pharmaobservatory/models/drug_label_safety_row'
|
|
149
169
|
require 'pharmaobservatory/models/drug_medicare_spend_response'
|
|
@@ -195,6 +215,23 @@ require 'pharmaobservatory/models/institutional_holdings_response'
|
|
|
195
215
|
require 'pharmaobservatory/models/institutional_holdings_row'
|
|
196
216
|
require 'pharmaobservatory/models/institutional_quarter_totals_response'
|
|
197
217
|
require 'pharmaobservatory/models/institutional_quarter_totals_row'
|
|
218
|
+
require 'pharmaobservatory/models/investigator_conditions_response'
|
|
219
|
+
require 'pharmaobservatory/models/investigator_conditions_row'
|
|
220
|
+
require 'pharmaobservatory/models/investigator_debarments_response'
|
|
221
|
+
require 'pharmaobservatory/models/investigator_debarments_row'
|
|
222
|
+
require 'pharmaobservatory/models/investigator_hospitals_response'
|
|
223
|
+
require 'pharmaobservatory/models/investigator_hospitals_row'
|
|
224
|
+
require 'pharmaobservatory/models/investigator_inspections_response'
|
|
225
|
+
require 'pharmaobservatory/models/investigator_inspections_row'
|
|
226
|
+
require 'pharmaobservatory/models/investigator_publications_response'
|
|
227
|
+
require 'pharmaobservatory/models/investigator_publications_row'
|
|
228
|
+
require 'pharmaobservatory/models/investigator_topics_response'
|
|
229
|
+
require 'pharmaobservatory/models/investigator_topics_row'
|
|
230
|
+
require 'pharmaobservatory/models/investigator_trials_response'
|
|
231
|
+
require 'pharmaobservatory/models/investigator_trials_row'
|
|
232
|
+
require 'pharmaobservatory/models/investigators_record'
|
|
233
|
+
require 'pharmaobservatory/models/investigators_response'
|
|
234
|
+
require 'pharmaobservatory/models/investigators_row'
|
|
198
235
|
require 'pharmaobservatory/models/investor_funds_response'
|
|
199
236
|
require 'pharmaobservatory/models/investor_funds_row'
|
|
200
237
|
require 'pharmaobservatory/models/investor_portfolio_response'
|
|
@@ -219,6 +256,8 @@ require 'pharmaobservatory/models/org_disclosures_response'
|
|
|
219
256
|
require 'pharmaobservatory/models/org_disclosures_row'
|
|
220
257
|
require 'pharmaobservatory/models/org_relationships_response'
|
|
221
258
|
require 'pharmaobservatory/models/org_relationships_row'
|
|
259
|
+
require 'pharmaobservatory/models/ownership_observations_response'
|
|
260
|
+
require 'pharmaobservatory/models/ownership_observations_row'
|
|
222
261
|
require 'pharmaobservatory/models/ownership_percentages_response'
|
|
223
262
|
require 'pharmaobservatory/models/ownership_percentages_row'
|
|
224
263
|
require 'pharmaobservatory/models/ownership_positions_response'
|
|
@@ -346,6 +385,8 @@ require 'pharmaobservatory/models/sponsor_delivery_response'
|
|
|
346
385
|
require 'pharmaobservatory/models/sponsor_delivery_row'
|
|
347
386
|
require 'pharmaobservatory/models/sponsor_patent_mentions_response'
|
|
348
387
|
require 'pharmaobservatory/models/sponsor_patent_mentions_row'
|
|
388
|
+
require 'pharmaobservatory/models/sponsor_publications_response'
|
|
389
|
+
require 'pharmaobservatory/models/sponsor_publications_row'
|
|
349
390
|
require 'pharmaobservatory/models/sponsor_recruitment_by_phase_response'
|
|
350
391
|
require 'pharmaobservatory/models/sponsor_recruitment_by_phase_row'
|
|
351
392
|
require 'pharmaobservatory/models/sponsor_recruitment_duration_response'
|
|
@@ -375,6 +416,8 @@ require 'pharmaobservatory/models/target_drugs_response'
|
|
|
375
416
|
require 'pharmaobservatory/models/target_drugs_row'
|
|
376
417
|
require 'pharmaobservatory/models/target_evidence_response'
|
|
377
418
|
require 'pharmaobservatory/models/target_evidence_row'
|
|
419
|
+
require 'pharmaobservatory/models/target_investigators_response'
|
|
420
|
+
require 'pharmaobservatory/models/target_investigators_row'
|
|
378
421
|
require 'pharmaobservatory/models/target_patent_mentions_response'
|
|
379
422
|
require 'pharmaobservatory/models/target_patent_mentions_row'
|
|
380
423
|
require 'pharmaobservatory/models/target_programs_response'
|
|
@@ -436,6 +479,7 @@ require 'pharmaobservatory/api/conditions_api'
|
|
|
436
479
|
require 'pharmaobservatory/api/datasets_api'
|
|
437
480
|
require 'pharmaobservatory/api/drugs_api'
|
|
438
481
|
require 'pharmaobservatory/api/hospitals_api'
|
|
482
|
+
require 'pharmaobservatory/api/investigators_api'
|
|
439
483
|
require 'pharmaobservatory/api/investors_api'
|
|
440
484
|
require 'pharmaobservatory/api/legal_entities_api'
|
|
441
485
|
require 'pharmaobservatory/api/managers_api'
|
metadata
CHANGED
|
@@ -1,14 +1,14 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.9
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
8
8
|
autorequire:
|
|
9
9
|
bindir: bin
|
|
10
10
|
cert_chain: []
|
|
11
|
-
date: 2026-10-
|
|
11
|
+
date: 2026-10-24 00:00:00.000000000 Z
|
|
12
12
|
dependencies:
|
|
13
13
|
- !ruby/object:Gem::Dependency
|
|
14
14
|
name: faraday
|
|
@@ -87,6 +87,11 @@ extensions: []
|
|
|
87
87
|
extra_rdoc_files: []
|
|
88
88
|
files:
|
|
89
89
|
- README.md
|
|
90
|
+
- docs/AnimalWelfareAssurancesResponse.md
|
|
91
|
+
- docs/AnimalWelfareAssurancesResponseBuild.md
|
|
92
|
+
- docs/AnimalWelfareAssurancesResponseFreshness.md
|
|
93
|
+
- docs/AnimalWelfareAssurancesResponseScope.md
|
|
94
|
+
- docs/AnimalWelfareAssurancesRow.md
|
|
90
95
|
- docs/ApiV1BaseApi.md
|
|
91
96
|
- docs/ApiV1WhoamiGet200Response.md
|
|
92
97
|
- docs/ApiV1WhoamiGet200ResponseLimits.md
|
|
@@ -97,9 +102,6 @@ files:
|
|
|
97
102
|
- docs/BiomarkerAlleleFrequenciesResponse.md
|
|
98
103
|
- docs/BiomarkerAlleleFrequenciesRow.md
|
|
99
104
|
- docs/BiomarkerAssayEvidenceResponse.md
|
|
100
|
-
- docs/BiomarkerAssayEvidenceResponseBuild.md
|
|
101
|
-
- docs/BiomarkerAssayEvidenceResponseFreshness.md
|
|
102
|
-
- docs/BiomarkerAssayEvidenceResponseScope.md
|
|
103
105
|
- docs/BiomarkerAssayEvidenceRow.md
|
|
104
106
|
- docs/BiomarkerAssayProvidersResponse.md
|
|
105
107
|
- docs/BiomarkerAssayProvidersRow.md
|
|
@@ -154,6 +156,16 @@ files:
|
|
|
154
156
|
- docs/CompanyAssetsRow.md
|
|
155
157
|
- docs/CompanyBiomarkerCapabilityResponse.md
|
|
156
158
|
- docs/CompanyBiomarkerCapabilityRow.md
|
|
159
|
+
- docs/CompanyCollaboratorsResponse.md
|
|
160
|
+
- docs/CompanyCollaboratorsRow.md
|
|
161
|
+
- docs/CompanyCompetitorActivityResponse.md
|
|
162
|
+
- docs/CompanyCompetitorActivityRow.md
|
|
163
|
+
- docs/CompanyCompetitorsResponse.md
|
|
164
|
+
- docs/CompanyCompetitorsRow.md
|
|
165
|
+
- docs/CompanyFinancialsResponse.md
|
|
166
|
+
- docs/CompanyFinancialsRow.md
|
|
167
|
+
- docs/CompanyFirmographicsResponse.md
|
|
168
|
+
- docs/CompanyFirmographicsRow.md
|
|
157
169
|
- docs/CompanyFundingEventsResponse.md
|
|
158
170
|
- docs/CompanyFundingEventsRow.md
|
|
159
171
|
- docs/CompanyFundingSummaryResponse.md
|
|
@@ -166,10 +178,14 @@ files:
|
|
|
166
178
|
- docs/CompanyRareDiseaseDeclarationsRow.md
|
|
167
179
|
- docs/CompanyTargetsResponse.md
|
|
168
180
|
- docs/CompanyTargetsRow.md
|
|
181
|
+
- docs/CompanyTimelineResponse.md
|
|
182
|
+
- docs/CompanyTimelineRow.md
|
|
169
183
|
- docs/CompanyTrialGeographyResponse.md
|
|
170
184
|
- docs/CompanyTrialGeographyRow.md
|
|
171
185
|
- docs/CompanyTrialSitesResponse.md
|
|
172
186
|
- docs/CompanyTrialSitesRow.md
|
|
187
|
+
- docs/CompanyUsPatentsResponse.md
|
|
188
|
+
- docs/CompanyUsPatentsRow.md
|
|
173
189
|
- docs/ConditionAdverseEventsResponse.md
|
|
174
190
|
- docs/ConditionAdverseEventsRow.md
|
|
175
191
|
- docs/ConditionBurdenResponse.md
|
|
@@ -178,6 +194,8 @@ files:
|
|
|
178
194
|
- docs/ConditionDeliveryRow.md
|
|
179
195
|
- docs/ConditionDrugsResponse.md
|
|
180
196
|
- docs/ConditionDrugsRow.md
|
|
197
|
+
- docs/ConditionInvestigatorOrganizationsResponse.md
|
|
198
|
+
- docs/ConditionInvestigatorOrganizationsRow.md
|
|
181
199
|
- docs/ConditionPrevalenceResponse.md
|
|
182
200
|
- docs/ConditionPrevalenceRow.md
|
|
183
201
|
- docs/ConditionPublicationsResponse.md
|
|
@@ -220,6 +238,8 @@ files:
|
|
|
220
238
|
- docs/DrugCombinationsRow.md
|
|
221
239
|
- docs/DrugDeclaredPatentsResponse.md
|
|
222
240
|
- docs/DrugDeclaredPatentsRow.md
|
|
241
|
+
- docs/DrugInvestigatorsResponse.md
|
|
242
|
+
- docs/DrugInvestigatorsRow.md
|
|
223
243
|
- docs/DrugLabelSafetyResponse.md
|
|
224
244
|
- docs/DrugLabelSafetyRow.md
|
|
225
245
|
- docs/DrugMedicareSpendResponse.md
|
|
@@ -273,6 +293,24 @@ files:
|
|
|
273
293
|
- docs/InstitutionalHoldingsRow.md
|
|
274
294
|
- docs/InstitutionalQuarterTotalsResponse.md
|
|
275
295
|
- docs/InstitutionalQuarterTotalsRow.md
|
|
296
|
+
- docs/InvestigatorConditionsResponse.md
|
|
297
|
+
- docs/InvestigatorConditionsRow.md
|
|
298
|
+
- docs/InvestigatorDebarmentsResponse.md
|
|
299
|
+
- docs/InvestigatorDebarmentsRow.md
|
|
300
|
+
- docs/InvestigatorHospitalsResponse.md
|
|
301
|
+
- docs/InvestigatorHospitalsRow.md
|
|
302
|
+
- docs/InvestigatorInspectionsResponse.md
|
|
303
|
+
- docs/InvestigatorInspectionsRow.md
|
|
304
|
+
- docs/InvestigatorPublicationsResponse.md
|
|
305
|
+
- docs/InvestigatorPublicationsRow.md
|
|
306
|
+
- docs/InvestigatorTopicsResponse.md
|
|
307
|
+
- docs/InvestigatorTopicsRow.md
|
|
308
|
+
- docs/InvestigatorTrialsResponse.md
|
|
309
|
+
- docs/InvestigatorTrialsRow.md
|
|
310
|
+
- docs/InvestigatorsApi.md
|
|
311
|
+
- docs/InvestigatorsRecord.md
|
|
312
|
+
- docs/InvestigatorsResponse.md
|
|
313
|
+
- docs/InvestigatorsRow.md
|
|
276
314
|
- docs/InvestorFundsResponse.md
|
|
277
315
|
- docs/InvestorFundsRow.md
|
|
278
316
|
- docs/InvestorPortfolioResponse.md
|
|
@@ -300,6 +338,8 @@ files:
|
|
|
300
338
|
- docs/OrgDisclosuresRow.md
|
|
301
339
|
- docs/OrgRelationshipsResponse.md
|
|
302
340
|
- docs/OrgRelationshipsRow.md
|
|
341
|
+
- docs/OwnershipObservationsResponse.md
|
|
342
|
+
- docs/OwnershipObservationsRow.md
|
|
303
343
|
- docs/OwnershipPercentagesResponse.md
|
|
304
344
|
- docs/OwnershipPercentagesRow.md
|
|
305
345
|
- docs/OwnershipPositionsResponse.md
|
|
@@ -436,6 +476,8 @@ files:
|
|
|
436
476
|
- docs/SponsorDeliveryRow.md
|
|
437
477
|
- docs/SponsorPatentMentionsResponse.md
|
|
438
478
|
- docs/SponsorPatentMentionsRow.md
|
|
479
|
+
- docs/SponsorPublicationsResponse.md
|
|
480
|
+
- docs/SponsorPublicationsRow.md
|
|
439
481
|
- docs/SponsorRecruitmentByPhaseResponse.md
|
|
440
482
|
- docs/SponsorRecruitmentByPhaseRow.md
|
|
441
483
|
- docs/SponsorRecruitmentDurationResponse.md
|
|
@@ -466,6 +508,8 @@ files:
|
|
|
466
508
|
- docs/TargetDrugsRow.md
|
|
467
509
|
- docs/TargetEvidenceResponse.md
|
|
468
510
|
- docs/TargetEvidenceRow.md
|
|
511
|
+
- docs/TargetInvestigatorsResponse.md
|
|
512
|
+
- docs/TargetInvestigatorsRow.md
|
|
469
513
|
- docs/TargetPatentMentionsResponse.md
|
|
470
514
|
- docs/TargetPatentMentionsRow.md
|
|
471
515
|
- docs/TargetProgramsResponse.md
|
|
@@ -528,6 +572,7 @@ files:
|
|
|
528
572
|
- lib/pharmaobservatory/api/datasets_api.rb
|
|
529
573
|
- lib/pharmaobservatory/api/drugs_api.rb
|
|
530
574
|
- lib/pharmaobservatory/api/hospitals_api.rb
|
|
575
|
+
- lib/pharmaobservatory/api/investigators_api.rb
|
|
531
576
|
- lib/pharmaobservatory/api/investors_api.rb
|
|
532
577
|
- lib/pharmaobservatory/api/legal_entities_api.rb
|
|
533
578
|
- lib/pharmaobservatory/api/managers_api.rb
|
|
@@ -546,6 +591,11 @@ files:
|
|
|
546
591
|
- lib/pharmaobservatory/api_client.rb
|
|
547
592
|
- lib/pharmaobservatory/api_error.rb
|
|
548
593
|
- lib/pharmaobservatory/configuration.rb
|
|
594
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response.rb
|
|
595
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_build.rb
|
|
596
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_freshness.rb
|
|
597
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_response_scope.rb
|
|
598
|
+
- lib/pharmaobservatory/models/animal_welfare_assurances_row.rb
|
|
549
599
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb
|
|
550
600
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb
|
|
551
601
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb
|
|
@@ -555,9 +605,6 @@ files:
|
|
|
555
605
|
- lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb
|
|
556
606
|
- lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb
|
|
557
607
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb
|
|
558
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_build.rb
|
|
559
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_freshness.rb
|
|
560
|
-
- lib/pharmaobservatory/models/biomarker_assay_evidence_response_scope.rb
|
|
561
608
|
- lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb
|
|
562
609
|
- lib/pharmaobservatory/models/biomarker_assay_providers_response.rb
|
|
563
610
|
- lib/pharmaobservatory/models/biomarker_assay_providers_row.rb
|
|
@@ -609,6 +656,16 @@ files:
|
|
|
609
656
|
- lib/pharmaobservatory/models/company_assets_row.rb
|
|
610
657
|
- lib/pharmaobservatory/models/company_biomarker_capability_response.rb
|
|
611
658
|
- lib/pharmaobservatory/models/company_biomarker_capability_row.rb
|
|
659
|
+
- lib/pharmaobservatory/models/company_collaborators_response.rb
|
|
660
|
+
- lib/pharmaobservatory/models/company_collaborators_row.rb
|
|
661
|
+
- lib/pharmaobservatory/models/company_competitor_activity_response.rb
|
|
662
|
+
- lib/pharmaobservatory/models/company_competitor_activity_row.rb
|
|
663
|
+
- lib/pharmaobservatory/models/company_competitors_response.rb
|
|
664
|
+
- lib/pharmaobservatory/models/company_competitors_row.rb
|
|
665
|
+
- lib/pharmaobservatory/models/company_financials_response.rb
|
|
666
|
+
- lib/pharmaobservatory/models/company_financials_row.rb
|
|
667
|
+
- lib/pharmaobservatory/models/company_firmographics_response.rb
|
|
668
|
+
- lib/pharmaobservatory/models/company_firmographics_row.rb
|
|
612
669
|
- lib/pharmaobservatory/models/company_funding_events_response.rb
|
|
613
670
|
- lib/pharmaobservatory/models/company_funding_events_row.rb
|
|
614
671
|
- lib/pharmaobservatory/models/company_funding_summary_response.rb
|
|
@@ -621,10 +678,14 @@ files:
|
|
|
621
678
|
- lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb
|
|
622
679
|
- lib/pharmaobservatory/models/company_targets_response.rb
|
|
623
680
|
- lib/pharmaobservatory/models/company_targets_row.rb
|
|
681
|
+
- lib/pharmaobservatory/models/company_timeline_response.rb
|
|
682
|
+
- lib/pharmaobservatory/models/company_timeline_row.rb
|
|
624
683
|
- lib/pharmaobservatory/models/company_trial_geography_response.rb
|
|
625
684
|
- lib/pharmaobservatory/models/company_trial_geography_row.rb
|
|
626
685
|
- lib/pharmaobservatory/models/company_trial_sites_response.rb
|
|
627
686
|
- lib/pharmaobservatory/models/company_trial_sites_row.rb
|
|
687
|
+
- lib/pharmaobservatory/models/company_us_patents_response.rb
|
|
688
|
+
- lib/pharmaobservatory/models/company_us_patents_row.rb
|
|
628
689
|
- lib/pharmaobservatory/models/condition_adverse_events_response.rb
|
|
629
690
|
- lib/pharmaobservatory/models/condition_adverse_events_row.rb
|
|
630
691
|
- lib/pharmaobservatory/models/condition_burden_response.rb
|
|
@@ -633,6 +694,8 @@ files:
|
|
|
633
694
|
- lib/pharmaobservatory/models/condition_delivery_row.rb
|
|
634
695
|
- lib/pharmaobservatory/models/condition_drugs_response.rb
|
|
635
696
|
- lib/pharmaobservatory/models/condition_drugs_row.rb
|
|
697
|
+
- lib/pharmaobservatory/models/condition_investigator_organizations_response.rb
|
|
698
|
+
- lib/pharmaobservatory/models/condition_investigator_organizations_row.rb
|
|
636
699
|
- lib/pharmaobservatory/models/condition_prevalence_response.rb
|
|
637
700
|
- lib/pharmaobservatory/models/condition_prevalence_row.rb
|
|
638
701
|
- lib/pharmaobservatory/models/condition_publications_response.rb
|
|
@@ -673,6 +736,8 @@ files:
|
|
|
673
736
|
- lib/pharmaobservatory/models/drug_combinations_row.rb
|
|
674
737
|
- lib/pharmaobservatory/models/drug_declared_patents_response.rb
|
|
675
738
|
- lib/pharmaobservatory/models/drug_declared_patents_row.rb
|
|
739
|
+
- lib/pharmaobservatory/models/drug_investigators_response.rb
|
|
740
|
+
- lib/pharmaobservatory/models/drug_investigators_row.rb
|
|
676
741
|
- lib/pharmaobservatory/models/drug_label_safety_response.rb
|
|
677
742
|
- lib/pharmaobservatory/models/drug_label_safety_row.rb
|
|
678
743
|
- lib/pharmaobservatory/models/drug_medicare_spend_response.rb
|
|
@@ -724,6 +789,23 @@ files:
|
|
|
724
789
|
- lib/pharmaobservatory/models/institutional_holdings_row.rb
|
|
725
790
|
- lib/pharmaobservatory/models/institutional_quarter_totals_response.rb
|
|
726
791
|
- lib/pharmaobservatory/models/institutional_quarter_totals_row.rb
|
|
792
|
+
- lib/pharmaobservatory/models/investigator_conditions_response.rb
|
|
793
|
+
- lib/pharmaobservatory/models/investigator_conditions_row.rb
|
|
794
|
+
- lib/pharmaobservatory/models/investigator_debarments_response.rb
|
|
795
|
+
- lib/pharmaobservatory/models/investigator_debarments_row.rb
|
|
796
|
+
- lib/pharmaobservatory/models/investigator_hospitals_response.rb
|
|
797
|
+
- lib/pharmaobservatory/models/investigator_hospitals_row.rb
|
|
798
|
+
- lib/pharmaobservatory/models/investigator_inspections_response.rb
|
|
799
|
+
- lib/pharmaobservatory/models/investigator_inspections_row.rb
|
|
800
|
+
- lib/pharmaobservatory/models/investigator_publications_response.rb
|
|
801
|
+
- lib/pharmaobservatory/models/investigator_publications_row.rb
|
|
802
|
+
- lib/pharmaobservatory/models/investigator_topics_response.rb
|
|
803
|
+
- lib/pharmaobservatory/models/investigator_topics_row.rb
|
|
804
|
+
- lib/pharmaobservatory/models/investigator_trials_response.rb
|
|
805
|
+
- lib/pharmaobservatory/models/investigator_trials_row.rb
|
|
806
|
+
- lib/pharmaobservatory/models/investigators_record.rb
|
|
807
|
+
- lib/pharmaobservatory/models/investigators_response.rb
|
|
808
|
+
- lib/pharmaobservatory/models/investigators_row.rb
|
|
727
809
|
- lib/pharmaobservatory/models/investor_funds_response.rb
|
|
728
810
|
- lib/pharmaobservatory/models/investor_funds_row.rb
|
|
729
811
|
- lib/pharmaobservatory/models/investor_portfolio_response.rb
|
|
@@ -748,6 +830,8 @@ files:
|
|
|
748
830
|
- lib/pharmaobservatory/models/org_disclosures_row.rb
|
|
749
831
|
- lib/pharmaobservatory/models/org_relationships_response.rb
|
|
750
832
|
- lib/pharmaobservatory/models/org_relationships_row.rb
|
|
833
|
+
- lib/pharmaobservatory/models/ownership_observations_response.rb
|
|
834
|
+
- lib/pharmaobservatory/models/ownership_observations_row.rb
|
|
751
835
|
- lib/pharmaobservatory/models/ownership_percentages_response.rb
|
|
752
836
|
- lib/pharmaobservatory/models/ownership_percentages_row.rb
|
|
753
837
|
- lib/pharmaobservatory/models/ownership_positions_response.rb
|
|
@@ -875,6 +959,8 @@ files:
|
|
|
875
959
|
- lib/pharmaobservatory/models/sponsor_delivery_row.rb
|
|
876
960
|
- lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb
|
|
877
961
|
- lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb
|
|
962
|
+
- lib/pharmaobservatory/models/sponsor_publications_response.rb
|
|
963
|
+
- lib/pharmaobservatory/models/sponsor_publications_row.rb
|
|
878
964
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb
|
|
879
965
|
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb
|
|
880
966
|
- lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb
|
|
@@ -904,6 +990,8 @@ files:
|
|
|
904
990
|
- lib/pharmaobservatory/models/target_drugs_row.rb
|
|
905
991
|
- lib/pharmaobservatory/models/target_evidence_response.rb
|
|
906
992
|
- lib/pharmaobservatory/models/target_evidence_row.rb
|
|
993
|
+
- lib/pharmaobservatory/models/target_investigators_response.rb
|
|
994
|
+
- lib/pharmaobservatory/models/target_investigators_row.rb
|
|
907
995
|
- lib/pharmaobservatory/models/target_patent_mentions_response.rb
|
|
908
996
|
- lib/pharmaobservatory/models/target_patent_mentions_row.rb
|
|
909
997
|
- lib/pharmaobservatory/models/target_programs_response.rb
|